Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)

This study has been terminated.
(Slow accrual)
Information provided by (Responsible Party):
Seppo W. Langer, Danish Oncological Lung Cancer Group Identifier:
First received: December 19, 2008
Last updated: January 23, 2016
Last verified: January 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2015
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)